Scleroderma lung disease: treatment with cyclophosphamide.

about

Scleroderma lung disease: treatment with cyclophosphamide.

Item

http://www.wikidata.org/entity/Q37754590

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Scleroderma lung disease: treatment with cyclophosphamide.

@en

Scleroderma lung disease: treatment with cyclophosphamide.

@nl

type

Item

label

Scleroderma lung disease: treatment with cyclophosphamide.

@en

Scleroderma lung disease: treatment with cyclophosphamide.

@nl

prefLabel

Scleroderma lung disease: treatment with cyclophosphamide.

@en

Scleroderma lung disease: treatment with cyclophosphamide.

@nl

P1476

Scleroderma lung disease: treatment with cyclophosphamide.

@en

P2093

Chris T Derk

http://www.w3.org/2001/XMLSchema#string

David Michel

http://www.w3.org/2001/XMLSchema#string

Lindsay Bischoff

http://www.w3.org/2001/XMLSchema#string

Steffan Schulz

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.

Cyclophosphamide versus placebo in scleroderma lung disease.

Interstitial lung disease in scleroderma.

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.

Evaluation and management of alveolitis and interstitial lung disease in scleroderma.

Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.

Pulmonary function tests, high-resolution computerized tomography, alpha1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis.

P304

849-852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2.6.849

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20476972

http://www.w3.org/2001/XMLSchema#string